Phase Ib clinical trial of IMCY-0098 in young adults with recent-onsent type 1 diabetes
Main Authors: | Van Rampelbergh, J, Boitard, C, Achenbach, P, Leslie, RD, Dayan, C, Keymeulen, B, Owen, K, Lapauw, B, Carlier, V, Ahangarani, RR, Gebruers, E, Vanderelst, L, Van Mechelen, M, Vandepapeliere, P |
---|---|
Format: | Conference item |
Language: | English |
Published: |
Springer
2019
|
Similar Items
-
First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes
by: Jean Van Rampelbergh, et al.
Published: (2023-05-01) -
An evaluation of the quality of IMCI assessments among IMCI trained health workers in South Africa.
by: Christiane Horwood, et al.
Published: (2009-01-01) -
Barriers to implementation of the HIV guidelines in the IMCI algorithm among IMCI trained health workers in Zambia
by: Kalesha Penny, et al.
Published: (2010-12-01) -
P014 (0098) CD47 IS EXPRESSED ON HODGKIN REED STERNBERG CELLS IN CLASSICAL HODGKIN LYMPHOMA
Published: (2018-10-01) -
Hypoxemia, hypoglycemia and IMCI danger signs in pediatric outpatients in Malawi
by: André Thunberg, et al.
Published: (2022-01-01)